Tests that use DNA from mother's blood to determine sex of fetus often effective

As a noninvasive method of determining the sex of a fetus, tests using cell-free fetal DNA obtained from the mother's blood after 7 weeks gestation performed well, while urine-based tests appear to be unreliable, according to a review and analysis of previous studies, reported in the August 10 issue of JAMA.

Noninvasive prenatal determination of fetal sex could provide an important alternative to invasive cytogenetic determination, which is currently the gold standard for determining sex and single-gene disorders. Amniocentesis has small but measurable rates of procedure-related ; and sonography can be performed as early as 11 weeks' gestation to determine fetal sex, although not reliably, according to background information in the article. "The availability of a reliable noninvasive alternative to determine fetal sex would reduce unintended fetal losses and would presumably be welcomed by carrying fetuses at risk for disorders," the authors write.

Using cell-free fetal DNA as a noninvasive method for prenatal determination of fetal sex provides an alternative to for some heritable disorders. In some countries, such as the Netherlands, the United Kingdom, France, and Spain, this testing has already transitioned to routine clinical care despite the absence of a formal assessment of its performance. "More recently, companies have begun offering this technology directly to the consumer over the Internet. The tests are marketed for nonmedical use to curious parents-to-be with promises in some cases of accuracy as high as 95 percent to 99 percent at as early as 5 to 7 weeks' gestation," according to background information in the article.

Stephanie A. Devaney, Ph.D., of the National Institutes of Health, Bethesda, Md., and colleagues performed a systematic review and meta-analysis of previous research to examine the analytic validity of cell-free fetal , which describes the test's ability to detect sequences within maternal samples, as well as the clinical validity of the test, as indicated by its ability to correctly identify fetal sex. The researchers selected 57 studies (which included 80 data sets [representing 3,524 male-bearing pregnancies and 3,017 female-bearing pregnancies]) for inclusion in the analysis.

The researchers found that the overall performance of the tests had sensitivity of 95.4 percent, specificity of 98.6 percent, positive predictive value, 98.8 percent, and negative predictive value, 94.8 percent. Performance was high using maternal blood. DNA methodology and gestational age had the largest effects on test performance, with real-time quantitative polymerase chain reaction (RTQ-PCR) outperforming conventional PCR. Test performance was high if performed using RTQ-PCR on a blood sample taken at a time during pregnancy when sufficient cell-free fetal DNA was present (7 weeks' gestation or later), with the best performance after 20 weeks' gestation. Testing performed prior to 7 weeks' gestation using blood, and all tests using urine, were found unreliable.

"The improved performance with later gestation is likely attributable to the increased concentration of cell-free fetal DNA within maternal blood as the fetus and placenta develop. This would explain the poor performance of the test prior to 7 weeks' gestation and the near-perfect performance in the third trimester," the authors write.

The researchers suggest that this "technology can be useful in clinical settings for early detection of at risk for sex-linked disorders requiring follow-up testing."

More information: JAMA. 2011;306[6]627-636

add to favorites email to friend print save as pdf

Related Stories

Noninvasive test for trisomy 21 closer at hand

Feb 10, 2011

In 1980 in the United States, approximately 4.5% of all pregnant women were of advanced maternal age. By 2007 that figure had increased to 14%. Women over 35 are at increased risk of giving birth to babies with trisomy 21. ...

New placenta screening for high-risk pregnancies

Apr 02, 2007

For the first time ever, a team of Toronto researchers are using a combination of ultrasound and blood tests to screen high-risk pregnant mothers for placental damage. By completing these non-invasive tests, most high-risk ...

Genetic test can scan fetus through mom's blood

Dec 08, 2010

Scientists have discovered a way to learn everything there is to know about a fetus's genetic make-up by taking a sample of the pregnant mother's blood, said a study released on Wednesday.

Recommended for you

With kids in school, parents can work out

14 hours ago

(HealthDay)—Back-to-school time provides an opportunity for parents to develop an exercise plan that fits into the family schedules, an expert suggests.

Obama offers new accommodations on birth control

18 hours ago

The Obama administration will offer a new accommodation to religious nonprofits that object to covering birth control for their employees. The measure allows those groups to notify the government, rather than their insurance ...

Use a rule of thumb to control how much you drink

18 hours ago

Sticking to a general rule of pouring just a half glass of wine limits the likelihood of overconsumption, even for men with a higher body mass index. That's the finding of a new Iowa State and Cornell University ...

User comments